版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
1、Objective To analyse the potential pathogenic role of EBV infection,ras mutations and FTase expression in the development of EBV-associated gastric carcinoma (EBVaGC). Methods Ras gene mutations were tested by PC
2、R-RFLP assay and FTase β mRNA expression was tested by RT-PCR assay in 13 EBVaGCs, 45 EBV-negative gastric carcinomas (EBVnGC) with matched clinicopathological parameters and 58 corresponding adjacent tissues of gast
3、ric carcinoma. The expression of EBV genes (nuclear antigen EBNA1 and EBNA2 genes,latent membrane protein LMP1 and LMP2A gene, and early genes BARF1 and BHRF1 ) was tested by RT-PCR-Southern assay. Results ①H-ras 1
4、2 codon mutation was detected in 2 cases of 58 gastric carcinomas (4.44%), all of 2 cases were in EBVnGCs.②The level of FTase β mRNA expression was 0.80±0.19 in 13 EBVaGCs and 0.96±0.43 in 45 EBVnGCs respectively. The di
5、fference between the two groups was not significant (t=1.93, P=0.06).The level of FTase β mRNA expression was 0.93±0.39 in 58 gastric carcinomas and 0.78±0.26 in 58 corresponding adjacent tissues respectively. The differ
6、ence between the two groups was significant (t=2.44, P=0.02<0.05).③EBNA1 mRNA was detected in all of 13 EBVaGCs,LMP2A mRNA was detected in 5 of 13 cases,while both EBNA2 and LMP1 mRNA were negative. Of the 13 EBV-positiv
7、e samples,6 exhibited BARF1 transcripts and 2 exhibited BHRF1 transcripts.④The level of FTase β mRNA expression was 0.76±0.24 in 5 LMP2A (0.73±0.19 in 6 BARF 1) positive samples and 0.86± 0.21 in 8 LMP2A (0.90 ± 0.21 in
8、7 BARF 1) negetive samples of 13 EBVaGCs respectively. The difference between the two groups was not significant (p>0.05). Conclusion ①The rate of ras gene mutations in gastric carcinomas is low. Ras gene mutations
9、 was not related with the development of EBVaGC.②There is no relation between the expression of FTase β mRNA and ras gene mutation. Famesylated proteins other than Ras are likely have a direct role in tumorigenesis.③The
10、lower level of FTase β mRNA expression in EBVaGC,the relationship between the absence of LMP1 and the lower level of FTase in EBVaGC,the different function of FTase between EBVaGC and EBVnGC ,these all should be studied
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 人胃癌組織中法尼基轉(zhuǎn)移酶基因表達與臨床病理特點、H-ras突變的關(guān)系.pdf
- 人子宮內(nèi)膜癌組織中法尼基轉(zhuǎn)移酶基因表達與K-ras突變的關(guān)系.pdf
- 原發(fā)性肝癌發(fā)生與ras基因突變及法呢基轉(zhuǎn)移酶過量表達的關(guān)系研究.pdf
- 胃癌組織中DNA聚合酶β基因突變和表達的研究.pdf
- 激素相關(guān)的糖基轉(zhuǎn)移酶基因克隆及轉(zhuǎn)基因水稻培育.pdf
- 胃癌線粒體細胞色素C氧化酶亞單位Ⅱ基因突變及意義.pdf
- 胃癌組織中TGFBR1基因突變及mRNA表達的研究.pdf
- 擬南芥耐鹽相關(guān)糖基轉(zhuǎn)移酶基因鑒定.pdf
- 口腔鱗癌組織中pten蛋白表達及基因突變檢測
- 胃癌的DNA甲基轉(zhuǎn)移酶表達及基因組DNA甲基化譜.pdf
- 口腔鱗癌組織中PTEN蛋白表達及基因突變的檢測.pdf
- 普通小麥中春化基因VRN1及甲基轉(zhuǎn)移酶基因的克隆及表達.pdf
- 氨基轉(zhuǎn)移酶基因(eR基因)的克隆及在黃瓜中的遺傳轉(zhuǎn)化.pdf
- 大腸癌中EGFR、Ras蛋白表達及K-ras基因突變的研究.pdf
- 黃芩中糖基轉(zhuǎn)移酶的基因克隆、原核表達及酶催化反應(yīng)研究.pdf
- 絲氨酸羥甲基轉(zhuǎn)移酶基因的克隆與表達.pdf
- 法尼基轉(zhuǎn)移酶抑制劑的設(shè)計、合成及藥理活性初篩.pdf
- 環(huán)糊精葡基轉(zhuǎn)移酶的基因分析、誘導(dǎo)表達及分離純化的研究.pdf
- EBV相關(guān)胃癌組織中CTHRC1基因甲基化及表達的研究.pdf
- 黑楊DNA甲基轉(zhuǎn)移酶基因的分離與表達分析.pdf
評論
0/150
提交評論